Date of Award
Thesis - SCU Access Only
Santa Clara : Santa Clara University, 2018.
Pancreatic cancer is expected to be the leading cause of cancer death by 2030.1 CA 19-9 is currently the most widely-used biomarker, but detection for this biomarker relies on monoclonal antibodies, which are expensive, require months to manufacture, and are ethically concerning.4 12 Through site-specific incorporation of an unnatural amino acid (L-DOPA), we are engineering a peptide that binds to a pancreatic cancer biomarker with strength comparable to a monoclonal antibody.11 By targeting a sugar molecule, we will expand the potential diagnostic and therapeutic applications of this cost-effective, stable, and ethical modular design.
Castillo, Sophia and Bartlett, Esther, "Engineering a Molecular Missile for Pancreatic Cancer Detection" (2018). Bioengineering Senior Theses. 74.
SCU Access Only
To access this paper, please log into or create an account in Scholar Commons using your scu.edu email address.